Last Updated: June 29, 2026

COMPOUND Drug Patent Profile

Name: COMPOUND Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Compound, and what generic alternatives are available?

Compound is a drug marketed by Alra and is included in one NDA.

The generic ingredient in COMPOUND is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for COMPOUND?
What are the global sales for COMPOUND?
What is Average Wholesale Price for COMPOUND?

Summary for COMPOUND

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	COMPOUND at DailyMed

Drug patent expirations by year for COMPOUND

US Patents and Regulatory Information for COMPOUND

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alra	COMPOUND 65	aspirin; caffeine; propoxyphene hydrochloride	CAPSULE;ORAL	084553-002	Aug 17, 1983		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for COMPOUND

Resemetirom compound patent expiry date?
What to call a compound with expired patent?
The basic compound patents for apixaban expired in november 2019 across major pharmaceutical markets followed by rivaroxaban in november 2020?
Ferrol compound with lipitor?
Process for licensing a compound from large pharma company?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.